We also demonstrated the potential applicability of LAMP1-based PET for a variety of carcinomas by performing LAMP1 immunofluorescence staining on human colon, breast, and prostate carcinoma samples, as well as genomic analysis. Here, LAMP1 is linked to carcinoma.